Lexaria Begins Dosing of Its Second GLP-1 Human Pilot Study
Go back to Lexaria Begins Dosing of Its Second GLP-1 Human Pilot Study| (NASDAQ: LEXX) | Delayed: 8.10 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.10 | 52 Week High | $ | |||
| Open | $8.10 | 52 Week Low | $ | |||
| Day High | $8.10 | P/E | N/A | |||
| Day Low | $8.10 | EPS | $ | |||
| Volume | 395 | |||||
| (NASDAQ: LEXXW) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $ | |||
| Open | $0.00 | 52 Week Low | $ | |||
| Day High | $0.00 | P/E | N/A | |||
| Day Low | $0.00 | EPS | $ | |||
| Volume | 247 | |||||
